Physician profile
Michael Stephen Wayne
NPI 1629177035
$4,822.62
in general payments reported to CMS, 2019-2025
34 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,485 · 2020: $1,067 · 2021: $1,280 · 2022: $990.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $559.28 | 2019-2022 | |
| Novo Nordisk INC | $557.13 | 2019-2022 | |
| Astrazeneca Pharmaceuticals Lp | $521.67 | 2019-2022 | |
| Glaxosmithkline, LLC. | $390.85 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $333.72 | 2019-2022 | |
| Amgen INC. | $320.17 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $298.80 | 2019-2022 | |
| Abbvie INC. | $237.21 | 2021-2022 | |
| Amarin Pharma, INC. | $215.28 | 2019-2022 | |
| Lilly USA, LLC | $204.82 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $174.77 | 2019-2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $153.90 | 2022 | |
| Novartis Pharmaceuticals Corporation | $125.66 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $123.95 | 2019-2021 | |
| Avanir Pharmaceuticals, INC. | $75.51 | 2021-2022 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $57.18 | 2020-2022 | |
| Otsuka America Pharmaceutical, INC. | $53.27 | 2022 | |
| Adlon Therapeutics L.P. | $48.33 | 2020-2021 | |
| Ironshore Pharmaceuticals INC. | $44.15 | 2019-2020 | |
| Esperion Therapeutics, INC. | $37.88 | 2020-2021 | |
| Astellas Pharma US INC | $35.75 | 2019 | |
| Allergan, INC. | $31.49 | 2019-2020 | |
| Neos Therapeutics, Lp | $29.98 | 2019 | |
| Eisai INC. | $28.20 | 2021 | |
| Jazz Pharmaceuticals INC. | $24.56 | 2020 | |
| Supernus Pharmaceuticals, INC. | $18.01 | 2021 | |
| Bausch Health US, LLC | $16.85 | 2022 | |
| Hologic Sales and Service, LLC | $15.61 | 2019 | |
| Sanofi-Aventis U.S. LLC | $15.58 | 2019 | |
| Ironwood Pharmaceuticals, INC | $15.03 | 2021 | |
| Dexcom, INC. | $14.83 | 2022 | |
| Sunovion Pharmaceuticals INC. | $14.83 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $14.32 | 2022 | |
| Sanofi Pasteur INC. | $14.05 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Wayne listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.